Published in Vaccine Weekly, March 9th, 2005
Sato joined Vertex in 1992 as vice president of research and was named president in 2000. She plans to continue working with companies in the areas of life science and biotechnology and on expanding her commitment to her interests in education.
Vertex also announced that Victor A. Hartmann, MD, will join Vertex as executive vice president, Strategic and Corporate Development. Comes to Vertex from Novartis Pharma AG and has more than 20 years of pharmaceutical industry experience primarily in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly